Zhou Y - Search Results

1

AIM2 promotes non-small-cell lung cancer cell growth through inflammasome-dependent pathway.

Zhang M, Jin C, Yang Y, Wang K, Zhou Y, Zhou Y, Wang R, Li T, Hu R. Zhang M, et al. Among authors: zhou y. J Cell Physiol. 2019 Nov;234(11):20161-20173. doi: 10.1002/jcp.28617. Epub 2019 Apr 5. J Cell Physiol. 2019. PMID: 30953357

2

Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway.

Zhou Y, Zhou Y, Yang M, Wang K, Liu Y, Zhang M, Yang Y, Jin C, Wang R, Hu R. Zhou Y, et al. Redox Biol. 2019 Apr;22:101131. doi: 10.1016/j.redox.2019.101131. Epub 2019 Jan 30. Redox Biol. 2019. PMID: 30735911 Free PMC article.

3

Absent in melanoma 2 suppresses epithelial-mesenchymal transition via Akt and inflammasome pathways in human colorectal cancer cells.

Yang Y, Zhang M, Jin C, Ding Y, Yang M, Wang R, Zhou Y, Zhou Y, Li T, Wang K, Hu R. Yang Y, et al. Among authors: zhou y. J Cell Biochem. 2019 Oct;120(10):17744-17756. doi: 10.1002/jcb.29040. Epub 2019 Jun 18. J Cell Biochem. 2019. PMID: 31210372

4

ROCK2 Confers Acquired Gemcitabine Resistance in Pancreatic Cancer Cells by Upregulating Transcription Factor ZEB1.

Zhou Y, Zhou Y, Wang K, Li T, Zhang M, Yang Y, Wang R, Hu R. Zhou Y, et al. Cancers (Basel). 2019 Nov 27;11(12):1881. doi: 10.3390/cancers11121881. Cancers (Basel). 2019. PMID: 31783584 Free PMC article.

5

HEATR1 deficiency promotes pancreatic cancer proliferation and gemcitabine resistance by up-regulating Nrf2 signaling.

Zhou Y, Wang K, Zhou Y, Li T, Yang M, Wang R, Chen Y, Cao M, Hu R. Zhou Y, et al. Redox Biol. 2020 Jan;29:101390. doi: 10.1016/j.redox.2019.101390. Epub 2019 Nov 20. Redox Biol. 2020. PMID: 31785531 Free PMC article.

6

Flumethasone enhances the efficacy of chemotherapeutic drugs in lung cancer by inhibiting Nrf2 signaling pathway.

Zhou Y, Zhou Y, Wang K, Li T, Yang M, Wang R, Chen Y, Cao M, Hu R. Zhou Y, et al. Cancer Lett. 2020 Apr 1;474:94-105. doi: 10.1016/j.canlet.2020.01.010. Epub 2020 Jan 16. Cancer Lett. 2020. PMID: 31954771

7

The CRTC1-NEDD9 signaling axis mediates lung cancer progression caused by LKB1 loss.

Feng Y, Wang Y, Wang Z, Fang Z, Li F, Gao Y, Liu H, Xiao T, Li F, Zhou Y, Zhai Q, Liu X, Sun Y, Bardeesy N, Wong KK, Chen H, Xiong ZQ, Ji H. Feng Y, et al. Among authors: zhou y. Cancer Res. 2012 Dec 15;72(24):6502-11. doi: 10.1158/0008-5472.CAN-12-1909. Epub 2012 Oct 16. Cancer Res. 2012. PMID: 23074285 Free PMC article.

8

MiR-1205 functions as a tumor suppressor by disconnecting the synergy between KRAS and MDM4/E2F1 in non-small cell lung cancer.

Yan H, Chen X, Li Y, Fan L, Tai Y, Zhou Y, Chen Y, Qi X, Huang R, Ren J. Yan H, et al. Among authors: zhou y. Am J Cancer Res. 2019 Feb 1;9(2):312-329. eCollection 2019. Am J Cancer Res. 2019. PMID: 30906631 Free PMC article.

9

Development of novel chromeno[4,3-c]pyrazol-4(2H)-one derivates containing piperazine as inhibitors of PI3Kα.

Yin Y, Zhou Y, Sha S, Wu X, Wang SF, Qiao F, Song ZC, Zhu HL. Yin Y, et al. Among authors: zhou y. Bioorg Chem. 2019 Nov;92:103238. doi: 10.1016/j.bioorg.2019.103238. Epub 2019 Aug 30. Bioorg Chem. 2019. PMID: 31499259

10

[Effects of NVP-BKM120 on the triple-negative breast cancer cell].

Zhang M, Zhou Y, Hu Y, Zhang J. Zhang M, et al. Among authors: zhou y. Zhonghua Yi Xue Za Zhi. 2015 Oct;95(40):3308-12. Zhonghua Yi Xue Za Zhi. 2015. PMID: 26815355 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72,081 results

Search Page

Filters